from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1922/-

LFCtreatmentdescriptionclass of inhibitor

-0.629

Amikacinug/mL Amikacintranslation

0.704

Cap5-10ug/mL Capreomycintranslation

0.105

Rox10-50 ug/mL Roxithromycintranslation

-0.632

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.954

Rif0.2-5ug/mL Rifampicintranscription

0.460

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.841

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.438

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.074

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.252

Clofazimine10-13 ug/mL Clofaziminerespiration

0.410

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.241

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.613

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.717

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.805

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.145

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.727

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.663

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.944

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

1.171

Nigericin50 uM Nigericinrespiration

0.840

TRC10-150 ug/mL Triclosanrespiration

-0.301

TRZ10-25 ug/mL Thioridazinerespiration

-0.472

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.306

menadione6-10 ug/mL Menadionerespiration

-0.730

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.160

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.306

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.656

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.912

NRP_1Non-replicating persistence stage 1dosRassociated

-0.280

Amp0.2mg/mL AmpicillincellWall

-0.597

Cephalexin20-100 ug/mL CephalexincellWall

0.062

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.511

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.009

EMB10-20 ug/mL EthambutolcellWall

-0.284

Eta12-40 ug/mL EthionamidecellWall

-0.456

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.133

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.020

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.113

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.115

BZA0.12 mg/mL BenzamidearomaticAmides

-0.229

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.206

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.043

H2O24 mM hydrogen peroxideDNAdamaging

-0.286

Levo10 ug/mL LevofloxacinDNAdamaging

-0.175

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.639

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.086

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.296

UVUV-irradiationDNAdamaging

-1.158

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.561

Antimycin12.5-50 ug/mL Antimycin A?

-0.416

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.260

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.534

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.967

PA8240.2-2 ug/mL PA-824?

0.504

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.123

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.305

Verapamil50 uM Verapamil?

-0.368

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.213

methoxatin10-20 ug/mL Methoxatin?